These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea. Kim ES; Kim HB; Kim G; Kim KH; Park KH; Lee S; Choi YH; Yi J; Kim CJ; Song KH; Choe PG; Kim NJ; Lee YS; Oh MD; PLoS One; 2014; 9(12):e114127. PubMed ID: 25485895 [TBL] [Abstract][Full Text] [Related]
10. Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan. Chen HA; Yang CJ; Tsai MS; Liao CH; Lee CH J Microbiol Immunol Infect; 2020 Dec; 53(6):909-915. PubMed ID: 32859532 [TBL] [Abstract][Full Text] [Related]
11. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Martínez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833 [TBL] [Abstract][Full Text] [Related]
12. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Filice GA; Nyman JA; Lexau C; Lees CH; Bockstedt LA; Como-Sabetti K; Lesher LJ; Lynfield R Infect Control Hosp Epidemiol; 2010 Apr; 31(4):365-73. PubMed ID: 20184420 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Bounthavong M; Hsu DI Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574 [TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus ocular infection: a 10-year hospital-based study. Hsiao CH; Chuang CC; Tan HY; Ma DH; Lin KK; Chang CJ; Huang YC Ophthalmology; 2012 Mar; 119(3):522-7. PubMed ID: 22176801 [TBL] [Abstract][Full Text] [Related]
15. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis using linezolid without removal of intrathecal infusion pump. Case report. Kallweit U; Harzheim M; Marklein G; Welt T; Pöhlau D J Neurosurg; 2007 Sep; 107(3):651-3. PubMed ID: 17886567 [TBL] [Abstract][Full Text] [Related]
19. Antibiotics for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: the challenge of outpatient therapy. Pate AJ; Terribilini RG; Ghobadi F; Azhir A; Barber A; Pearson JM; Kalantari H; Hassen GW Am J Emerg Med; 2014 Feb; 32(2):135-8. PubMed ID: 24238483 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates. Huang WC; Lee CH; Liu JW J Microbiol Immunol Infect; 2010 Dec; 43(6):470-7. PubMed ID: 21195973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]